Kidney Disease
-
Hinton lab grows, American Physiological Society award adds Clintoria Williams as Visiting Scholar
Clintoria Williams, associate professor in the Department of Neuroscience, Cell Biology and Physiology at Wright State University, has received the John F. Perkins, Jr. Research Career Enhancement Award from the American Physiological Society. This will enable her to join Vanderbilt as a visiting scholar in the Department of Molecular Physiology and Biophysics for four months to collaborate more closely with Antentor Hinton Jr., assistant professor in the department. Read MoreMay 7, 2024
-
VUMC study finds molecular switch key to repair of kidney damage
Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair. Read MoreFebruary 7, 2024
-
Computer scientist wins $2.7M NIH grant to develop AI-empowered 3D computer vision tool to better diagnose kidney diseases
Vanderbilt computer scientist Yankai Huo is working with key clinical collaborators at Vanderbilt University Medical Center to develop a quantitative and reproducible 3D analytics tool for large-scale digital analysis of kidney tissues and biopsies. Read MoreApril 12, 2023
-
VUMC researchers upend dogma about vasopressin production
Vanderbilt investigators have discovered that vasopressin, which has long been thought to be produced only in the brain, is also produced in the kidney. Read MoreJanuary 5, 2023
-
Novel therapeutic target identified for chronic kidney disease
Vanderbilt investigators have discovered a molecular mechanism that promotes chronic kidney disease following kidney injury. Read MoreDecember 15, 2022
-
Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage. Read MoreOctober 20, 2022
-
Study sheds light on the dark side of obesity
Vanderbilt research that promotes the anti-inflammatory pathway in macrophages could also reduce some of the bad side effects of obesity. Read MoreMay 12, 2022
-
VUMC study raises hope for improving treatment of kidney disease
Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure. Read MoreFebruary 2, 2022
-
Study shines light on architecture of kidney disease
A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues. Read MoreSeptember 25, 2019
-
Diabetes drug study explores cardiovascular risks for patients with kidney disease
An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. Read MoreSeptember 25, 2019